Galectin Therapeutics Inc (GALT): Shares Outstanding
65.20M
As of 2025-12-31
66.31M
As of 2026-06-30
+3.1%
3-year compound annual growth
+2.7%
5-year compound annual growth
+8.5%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 65.20M | +3.2% | 2026-03-31, Balance as of period end |
| 2024-12-31 | 63.16M | +2.1% | 2026-03-31, Balance as of period end |
| 2023-12-31 | 61.85M | +4.1% | 2025-03-31, Balance as of period end |
| 2022-12-31 | 59.43M | +0.1% | 2024-03-29, Balance as of period end |
| 2021-12-31 | 59.34M | +4.0% | 2023-03-30, Balance as of period end |
| 2020-12-31 | 57.08M | +0.3% | 2022-03-31, Balance as of period end |
| 2019-12-31 | 56.89M | +38.1% | 2021-03-31, Balance as of period end |
| 2018-12-31 | 41.19M | +15.1% | 2020-03-16, Balance as of period end |
| 2017-12-31 | 35.79M | +8.7% | 2019-03-06, Balance as of period end |
| 2016-12-31 | 32.91M | +14.2% | 2018-03-29, Balance as of period end |
| 2015-12-31 | 28.83M | +29.4% | 2017-03-28, Balance as of period end |
| 2014-12-31 | 22.28M | +21.2% | 2016-03-15, Balance as of period end |
| 2013-12-31 | 18.39M | +14.5% | 2015-03-18, Balance as of period end |
| 2012-12-31 | 16.06M | +24.3% | 2014-03-21, Balance as of period end |
| 2011-12-31 | 12.92M | +21.3% | 2013-03-29, Balance as of period end |
| 2010-12-31 | 10.65M | n/a | 2012-03-30, Balance as of period end |